In the lab breach, virus was detected in a sewage sample and was genetically similar to vaccine stocks used at the facility, then a lab worker tested positive.
The NSABB endorses findings from two of its working groups, one on oversight of potential pandemic pathogens and the other on dual-use research of concern.
Draft recommendations from a panel that advises the NIH would tighten oversight of potentially dangerous pathogens.
Work on a hybrid SARS-CoV-2 virus has inflamed more controversy about lab biosafety and federal oversight
Biopharmaceutical company Spero Therapeutics announced today that it has entered into a licensing agreement with GSK for the antibiotic tebipenem pivoxil hydrobromide (HBr).
A retrospective study of 17 COVID-19 survivors with lingering symptoms reveals that 10 (59%) had nerve damage, which the researchers said could have been triggered by potentially treatable infection-related immune dysfunction.
Upwards of 700,000—perhaps as many as 1.6 million—US COVID-19 survivors haven't recovered their sense of smell after more than 6 months, according to a research letter yesterday in JAMA Otolaryngology-Head & Neck Surgery.
New research from the Mayo Clinic shows monoclonal antibodies reduce the risk of hospitalization 77% in 1,395 patients who had breakthrough COVID-19 infections. The research was published yesterday in the Journal of Infectious Diseases.
Implementation of a test that provides rapid bacterial identification and susceptibility results from positive blood cultures shortened the time to optimal antibiotic therapy and reduced unnecessary antibiotic exposure in hospitalized patients with bacteremia, researchers reported late last week in the Journal of Antimicrobial Chemotherapy.
The US Centers for Disease Control and Prevention (CDC) announced yesterday that the Pan American Health Organization (PAHO)/World Health Organization (WHO) have designated the CDC's Center for Global Health as a PAHO/WHO Collaborating Center for Biosafety and Biosecurity.
